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Abstract
Background: To identify the spread of nosocomial infections and halt outbreak development caused by Escherichia coli
that carry multiple antibiotic resistance factors, such as extended-spectrum beta-lactamases (ESBLs) and carbapenemases,
is becoming demanding challenges due to the rapid global increase and constant and increasing influx of these bacteria
from the community to the hospital setting. Our aim was to assess a reliable and rapid typing protocol for ESBL-E. coli,
with the primary focus to screen for possible clonal relatedness between isolates. All clinical ESBL-E. coli isolates, collected
from hospitals (n= 63) and the community (n = 41), within a single geographical region over a 6 months period, were
included, as well as clinical isolates from a polyclonal outbreak (ST131, n = 9, and ST1444, n = 3). The sporadic cases
represented 36 STs, of which eight STs dominated i.e. ST131 (n= 33 isolates), ST648 (n= 10), ST38 (n= 9), ST12 and 69
(each n = 4), ST 167, 405 and 372 (each n= 3). The efficacy of multiple-locus variable number tandem repeat analysis
(MLVA) was evaluated using three, seven or ten loci, in comparison with that of pulsed-field gel electrophoresis (PFGE)
and multi locus sequence typing (MLST).
Results: MLVA detected 39, 55 and 60 distinct types, respectively, using three (GECM-3), seven (GECM-7) or ten
(GECM-10) loci. For GECM-7 and −10, 26 STs included one type and eleven STs each included several types, the
corresponding numbers for GECM-3 were 29 and 8. The highest numbers were seen for ST131 (7,7 and 8 types,
respectively), ST38 (5,5,8) and ST648 (4,5,5). Good concordance was observed with PFGE and GECM-7 and −10,
despite fewer types being identified with MLVA; 78 as compared to 55 and 60 types. The lower discriminatory
power of MLVA was primarily seen within the O25b-ST131 lineage (n = 34) and its H30-Rx subclone (n = 21).
Epidemiologically unrelated O25b-ST131 isolates were clustered with O25b-ST131 outbreak isolates by MLVA,
whereas the ST1444 outbreak isolates were accurately distinguished from unrelated isolates.
Conclusion: MLVA, even when using only three loci, represents an easy initial typing tool for epidemiological
screening of ESBL-E. coli. For the ST131-O25b linage, complementary methods may be needed to obtain sufficient
resolution.
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Background
Antibiotic resistance in pathogens is a growing problem in
all parts of the world, making infectious diseases that have
been curable for decades increasingly difficult to treat [1].
Enterobacteriaceae that harbour resistance mechanisms,
such as extended-spectrum beta-lactamases (ESBL) and
carbapenemases, pose major threats to human health [2].
Enterobacteriaceae harbouring ESBL were comparatively
rare in Sweden and the other Scandinavian countries at
the time of this study [3–6]. However, a few nosocomial
outbreaks were reported [7–9]. Data from the European
Centre for Disease Prevention and Control (ECDC) sur-
veillance program show that the prevalence of E. coli
with resistance to third generation cephalosporins is
still low in the Scandinavian countries [10]. Further
data have demonstrated that the prevalence with regard
to ESBL-producing Enterobacteriaceae is low, although
on the rise [11–14].
Escherichia coli Sequence Type 131 (ST131) has
emerged as an important human pathogen and intestinal
colonizer, having spread rapidly throughout the world
and resulting in community and hospital-acquired urin-
ary tract and bloodstream infections. E. coli ST131 is
also considered to be a significant contributor in the in-
crease in ESBL prevalence among infectious strains of E.
coli [15, 16]. However, it has become evident that E. coli
ST131 is not a single genotypic lineage, particularly
demonstrable using pulsed-field gel electrophoresis
(PFGE) for genomic profiling, but rather is an aggregate
of distinctive sub-lineages. Its increasing antimicrobial
resistance, including ESBL, has a strong cladistic base
within the O25b:H4 serogroup and its fimH30 lineage,
with subsequent expansion to the H30R and H30-Rx
subclones [2, 17, 18].
Enterobacteriaceae that harbour multiple resistance
are widely distributed throughout the community, as
part of the normal microbiota, even in areas of low
prevalence of antibiotic resistance, such as in Scandi-
navia [11, 13]. Therefore, it is no longer feasible to im-
plement surveillance measures for all isolates. Instead,
the focus must be on identifying spread and timely alerts
to halt outbreaks. For an outbreak situation that is
epidemiologically evident, whole genome sequencing
(WGS) is becoming the method of choice to confirm
strain relatedness between isolates [19]. However, for
standard consecutive infection control surveillance,
there is a need for reliable typing systems that are easy
and quick to handle with the primary aim to screen for
clonal relatedness and often exclude rather than confirm
strain identity. PFGE has been used extensively, but is
becoming outdated due to several drawbacks, and, for
the present purpose, is too slow and cumbersome.
Several studies have explored the use of variable number
of tandem repeat DNA sequences as a means of strain
typing. Multiple-locus variable number of tandem repeat
analysis (MLVA) is used to generate a DNA fingerprint
of a bacterial isolate by PCR amplification and subse-
quent fragment analyses of target regions featuring
Variable Numbers of Tandem Repeats (VNTR) distrib-
uted throughout the bacterial genome, and is increas-
ingly being used for subtyping various species [20–22].
We have previously reported on the successful applica-
tion of a generic E. coli MLVA (GECM) that uses 10 loci,
as described by Lobersli et al. [23], to investigate a poly-
clonal plasmid-mediated ESBL-E. coli and K. pneumo-
niae outbreak [7, 24]. The GECM was shown to produce
results that were comparable to those obtained with
genomic profiling using PFGE. In most situations, iso-
lates obtained during an outbreak will have an identical
and unique typing profile. However, if the same profile is
observed in isolates that are unrelated to that outbreak,
information on the background distribution of the pro-
file within the local bacterial population and a reason-
able timeframe, becomes critical [25]. With the aim of
deriving a typing method for ESBL-E. coli that can be
used for standard consecutive infection control surveil-
lance, we evaluated the efficacy of MLVA, using different
numbers of loci, and compared it with PFGE and multi
locus sequence typing (MLST), to distinguish consecu-
tively identified ESBL-E. coli isolates, including the above
mentioned outbreak isolates, in a municipal area in




All of the ESBL-E. coli isolates detected at the Clinical
Bacteriology Laboratory, Sahlgrenska University Hospital
since 2003 are routinely stored at −70 °C and the epi-
demiological data linked to the isolates are documented.
A previously described polyclonal, plasmid-mediated
outbreak caused by ESBL-producing E.coli of two STs as
well as K. pneumoniae, took place from September 2008
until it finally was revealed and terminated in December
2008 [7, 24]. For this study, almost all clinical, non-
duplicate ESBL-E. coli isolates detected during the
ongoing outbreak period and through the follow-up
period, i.e. until February 2009, were included. Thus, all
sporadic cases that could be retrieved (104/108) for fur-
ther analyses were included. In addition, all clinical
ESBL-E. coli samples, i.e. 12 isolates from seven patients,
that were part of the above-mentioned outbreak were
included. No additional outbreaks occurred during the
study period, according to standard consecutive epi-
demiological surveillance performed at the time. The
sporadic cases included isolates collected both from the
hospital (n = 63) as well as from the community setting
(n = 41). They corresponded to 36 STs, of which ST131
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was the most common (n = 42). For 21 STs, only a single
isolate was detected. For the sporadic cases, no ST dom-
inated in a particular setting. The E. coli outbreak iso-
lates belonged to ST131 (n = 9) and ST1444 (n = 3).
The E. coli isolates were identified according to the
routine protocol at the laboratory, using conventional
biochemical tests. Antibiotic susceptibility was deter-
mined, using the disc diffusion assay and breakpoints in
practice at the time, according to the Swedish Reference
Group for Antibiotics (SRGA) and in accordance with
the recommendations of the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) [26].
Cephalosporin-resistant isolates were screened for the
ESBL phenotype, using the double-disc diffusion assay
[27]. For this study, frozen samples were retrieved and
plated on blood agar medium. Two to five bacterial col-
onies from overnight cultures were suspended in 100 μl
EDTA, heated for 15 min at 95 °C, and centrifuged at
18,000 × g for 5 min. Cell supernatants, containing the
bacterial DNA, were separated from pelleted cell debris
and used for the subsequent DNA analyses.
Genotypic detection of blaCTX-M, blaTEM, blaOXA, blaSHV
All E. coli isolates that were characterized phenotypically
as being ESBL-positive were confirmed, using a multi-
plex PCR assay for detecting the genes for the CTX-M-,
TEM-, OXA- and SHV-β-lactamases, as previously
described [28]. Subsequently, the isolates were investi-
gated for CTX-M phylogroups, using a standardised
PCR assay and a Taq Man PCR protocol [29].
Pulsed-field gel electrophoresis
PFGE was performed, following the extraction of gen-
omic DNA and digestion with restriction enzyme XbaI,
as described previously by Welinder-Olsson et al. [30].
Briefly, XbaI digested DNA was electrophoresed in 1%
agarose in 0.5 × TBE at 14 °C for 26 h, using the Gene
Path system (Bio-Rad Laboratories, Sweden), set at 6 V/
cm, with pulse times linearly increasing from 12.6 s ini-
tial switch time to 40 s final switch time. XbaI-digested
DNA from Salmonella serotype Braenderup H9812 was
included as a normalisation standard on every gel. The
DNA band patterns were analysed, using the BioNu-
merics software version 6.6 (Applied Maths NV, Sint-
Martens-Latem, Belgium) with the Dice coefficient for
calculating pair-wise similarities, and the UPGMA algo-
rithm for constructing dendrograms of estimated re-
latedness. Position tolerance and optimisation were set
at 1.0. Bands within the size range 453-78 kb were in-
cluded in the analysis. Interpretation of strain similarity
was performed according to previously published guide-
lines [25, 31, 32]. For the present study, strains were
assigned the same PFGE-type if the similarity was ≥80%.
In addition to using the BioNumerics software for
analysing band pattern similarity, visual interpretation of
band differences was performed to ascertain the results.
As generally recommended, isolates with as many as
three band differences were then considered the same
PFGE-type, corresponding to ≥80% similarity. The visual
analyses of band patterns did not alter the results from
using similarity index. The PFGE profile types were arbi-
trarily designated using a letter combination, the desig-
nated letters not indicating any similarity of pattern nor
subtypes. For comparison between MLVA and PFGE
results, PFGE types were also defined by using ≥70%
similarity and ≥90% similarity.
Multi-Locus Sequence Typing (MLST)
MLST was performed according to the method of the E.
coli MLST database website [33] as previously described
[7]. Representative isolates of all MLVA-types irrespect-
ive of number of loci used, as well as all PFGE-types,
were sequenced. The sequences were submitted to the
MLST database for E. coli and the respective sequence
types were determined.
Identification of E. coli O25b- ST131 and its H30-Rx
subclone
Detection of the O25b-ST131 strain-type was performed,
using an O25b-ST131 allele-specific pabB PCR [34]. The
adk-gene was used as the positive control for the PCR
assessing DNA quality, as described previously [7]. The
H30 and H30-Rx subclones were detected, as described
previously [17, 35].
Generic E. coli MLVA (GECM)
GECM was performed targeting seven tandem sequence
repeats (GECM-7; CVN001, CVN002, CVN003, CVN004,
CVN007, CVN014, CVN015) initially described by Lind-
stedt et al., [36]. In addition, CVN016 and CVN017 and
one regularly interspersed short palindromic repeat
(CCR001), that have been described to increase the
discriminatory power of this MLVA, were included
(GECM-10) [23].
Four PCR assays with HotStarTaq Master Mix
(Qiagen, Hilden, Germany) and multiple dye-labelled
amplification primers were used, as described previously
[23, 36]. The first PCR contained primers for the
CVN003 and CVN014 loci, the second PCR had primers
for CVN001, CVN004, CVN007 and CVN015, the third
PCR contained primers for CCR001, CVN016 and
CVN017, and the fourth PCR was a single PCR for the
CVN002 locus. The final concentrations of the PCR
primers were slightly modified, as described previously
[7, 23, 36]. After the PCR amplifications, the first and
fourth multiplex PCR products were pooled. To this
pooled solution, 0.5 μl of the Geneflo-625 TAMRA
(CHIMERx) internal size standard was added, with 12 μl
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of formamide, and subsequently electrophoresed, using
the ABI-310 Genetic Analyzer (Applied Biosystems,
Foster City, CA, USA), as described previously [36]. The
second multiplex PCR product was handled in the same
manner, whereas the third PCR product was mixed with
Genescan-Liz600 (Applied Biosystems) instead of Geneflo-
625 TAMRA. For all the loci, all of the individual peaks
were identified, based on the dye-labelling and size. In
addition to the length of each locus (allowing for ±1.5 base
pairs difference), the numbers of repeats were calculated
according to Lobersli et al. [23]. If no PCR-product was
detected, the locus was denoted as ʻNʼ and if no repeats
could be calculated, it was denoted ʻ0ʼ. All the GECM
profile types were arbitrarily designated.
Comparison of MLVA and PFGE results
The partitions comparison computer software was
used for the assessment of diversity (Simpson’s index
of diversity) [37].
Results
Overall strain typing results
Of the 116 isolates included, nine O25b-ST131 isolates
and three ST1441 isolates were linked to the previously
described polyclonal outbreak [7, 24], while the remaining
isolates had no known epidemiological relationship and
thus were considered sporadic cases. The sporadic cases
represented 36 STs of which eight STs dominated i.e. ST
131 (n = 33 isolates), ST648 (n = 10), ST38 (n = 9), ST12
and 69 (each n = 4), ST 167, 405, and 372 (each n = 3).
Two isolates were found in each of ST 10, 43, 58, 393, 443
and 1284 and the remaining STs were represented by only
one isolate each.
All isolates were typeable by generic E. coli MLVA.
When the initial seven loci were analysed (GECM-7), 55
strain types were identified that differed by at least one al-
lele; 38 of these were singletons, the remainder contained
two to six isolates each, with the exception of two large
clusters of isolates that were assigned to the O25b-ST131
lineage (Tables 1 and 2). Isolates belonging to the O25b-
Table 1 Correlation between generic E. coli MLVA using seven loci (GECM-7) and PFGE using >80% similarity index for the
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Total
JB 1b 2 3
CK 3 3
DA 1b 1b 2
GA 1 1b 2
IA 2b 2
A 1b 9a 10
O 3b 3










Non-typeable 1 1 1 3
Singleton by PFGE
and cluster by GECM-7




Total 2 4 2 4 2 2 5 6 2 3 17 14 4 3 2 3 2 Singleton GECM-7 39 Total 116
aIsolates belonging to a polyclonal outbreak. bIncludes isolates belonging to the H30-Rx subclone (n = 21). cIncludes one isolate non-typeable by PFGE
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ST131 lineage (n = 34) and its subclones H30 (n = 33) and
H30-Rx (n = 21) were clearly distinguishable from the
other isolates and were found within three GECM-7 types
(Fig. 1 and Table 1).
Four of the 116 isolates could not be typed using PFGE.
Using a cut-off of ≥80% similarity for designation of PFGE
types and excluding nontypable isolates, 78 types were
identified, of which 61 were singletons (Tables 1 and 2).
The remaining 17 clusters consisted of two to four iso-
lates, apart from one larger cluster that included outbreak
isolates (PFGE type A). The O25b-ST131 lineage and the
H30-Rx subclone were detected within 14 and 12 different
Table 2 Comparison of the numbers of types generated by the various MLVA and PFGE. The numbers of types generated by the
various MLVA using three (GECM-3), seven (GECM-7), or ten (GECM-10) loci, respectively, in comparison with that of PFGE using
>80% similarity index for the designation of types, for the typing of 116 ESBL-E. coli isolates belonging to either the ST131-O25b
linage (n = 34) or not
Number of isolates within a type GECM-3 GECM-7 GECM-10 PFGE
Non-O25b O25b Non-O25b O25b Non-O25b O25b Non-O25b O25b
Singleton 22 0 38 0 44 0 60a 6b
2–4 11 1 11 1 11 1 9b 7
5–9 2 0 3 0 2 0 0 0
≥10 1 2 0 2 0 2 0 1
Total number of types 36 3 52 3 57 3 69 14
Simpsons index of diversity (CI 95%) 0.96 (0.94–0.98) 0.59 - 0.98 (0.97–0.99) 0.59 - 0.99 (0.98–0.99) 0.59 - 1.0 (0.99–1.0) 0.89 -
aIsolates non typeable by PFGE (n = 4) included, each with an individual designation and thus accounted for as singeltons. bPFGE type JB is included in both the
non-O25b and O25b isolates (however both ST131), so it is listed in both columns
Fig. 1 PFGE profile in relation to MLVA profile for isolates belonging to the O25b-ST131 linage. PFGE profile in relation to MLVA profile for 34 ESBL-E.
coli isolates, including both sporadic cases and the outbreak isolates (shaded in grey) belonging to the O25b-ST131 lineage and its subclone H30Rx
(pos). Names of PFGE-type using > 80% similarity index are given. The GECM profile corresponds to the number of repeats in the following loci; CVN
001, CVN 002, CVN 003, CVN 004, CVN 007, CVN 014, CVN 015, CCR 001, CVN 016 and CVN 017. N denotes no PCR-product and 0 denotes that no
repeats could be calculated. The GECM-7 types are given, which correspond to MLVA using the first seven loci of GECM-10. Resistance (R) or sensitivity
(S) for ciprofloxacin, trimethoprim and tobramycin
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PFGE types, respectively. These clusters included one to
four isolates each, with the exception of one of the out-
break clusters.
Most of the sporadic isolates were resistant to cipro-
floxacin (82%, 85/104), trimethoprim (79%, 71/104) or
both (66%, 69/104). Resistance to tobramycin was less
frequent (39%, 41/104), as was resistance to all three an-
tibiotics (36%, 37/104). The corresponding resistance
rates for the nine ST131-O25b outbreak isolates were;
tobramycin 8/9, trimethoprim 9/9 and ciprofloxacin 0/9,
and for the three ST1444 outbreak isolates 2/3, 3/3, and
3/3, respectively. The antibiograms showed no coher-
ence with GECM-7 types or PFGE-types (Figs. 1 and 2).
The vast majority of the isolates carried ESBLs of the
CTX-M-1 (90/116) or CTX-M-9 (20/116) phylogroup.
Comparison of MLVA and MLST
Representative isolates from each of the MLVA-types
were analysed by E. coli MLST. Among the 37 STs
detected, 26 STs included only one MLVA-type deter-
mined by using 7 loci (GECM-7), each with one to three
isolates/type. The remaining 11 STs included several, i.e.
two to seven, GECM-7 types within each ST, the highest
numbers of types seen for ST648 (5 types, 10 isolates),
ST38 (5 types and 9 isolates) and ST69 (4 types, 4
isolates) in addition to ST131. The latter included 42
isolates separated into seven GECM-7 types, of which
the O25b-ST131 lineage corresponded to three types (34
isolates). The nine O25b negative isolates of ST131 were
found within four types with one to three isolates/type.
Using 10 loci (GECM-10) resulted in almost identical
results as those of GECM-7, i.e. 26 STs included only
one GECM-10 type and 11 STs several types. Only two
STs were further subdivided into additional types, i. e.
ST131 and ST38, by adding the three extra loci of
GECM-10 to those of the GECM-7 protocol. Using only
three loci (GECM-3), 29 ST included only one MLVA-
type, and eight STs each included two to seven types,
with one less type in ST405, 648, 617 and 1284, as com-
pared to using seven or ten loci.
Altogether, the highest numbers of MLVA-types
were seen for ST131 (7,7 and 8 types for 3,7 and 10
loci, respectively), followed by ST38 (5,5,8 types),
ST648 (4,5,5 types), ST69 (4,4,4 types), ST12 (3,3,3
types), ST 10, 58, 443, (2,2,2 types), and ST 405, 617,
1284 (1,2,2 types).
Fig. 2 PFGE profile in relation to MLVA profile for isolates, not part of the O25b-ST131 lineage. PFGE profile in relation to MLVA profile for 29 ESBL-E.
coli isolates, each representing PFGE types with several isolates and not part of the O25b-ST131 lineage. All are sporadic cases with the exception of
one isolate shaded in grey that represents three outbreak isolates. Names of PFGE-type using > 80% similarity index are given. The GECM
profile corresponds to the number of repeats in the following loci; CVN 001, CVN 002, CVN 003, CVN 004, CVN 007, CVN 014, CVN 015,
CCR 001, CVN 016 and CVN 017. The GECM-7 types are given which corresponds to MLVA using the first seven loci of GECM-10. Resistance (R) or
sensitivity (S) for ciprofloxacin, trimethoprim and tobramycin
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Comparison of MLVA (GECM-7) and PFGE for strain typing
The correlation, between GECM-7 and PFGE was good,
as demonstrated in Table 1, when using a threshold of
≥80% similarity for the designation of PFGE types, even
though GECM-7 exhibited a lower discriminatory cap-
acity than PFGE, especially for the O25b-ST131 isolates
(Tables 1 and 2). The PFGE-similarity index was in the
range of 41–67% within a given GECM-7 type, except
for those cases with complete concordance. Neither use
of ≥70% nor ≥90% similarity for designation of PFGE
types changed the level of concordance with MLVA.
The number of singletons detected by PFGE were al-
most twice as many as determined by GECM-7. Also, all
of the PFGE non-typeable isolates were typeable by
GECM-7. In the cases where a GECM-7 type included
isolates belonging to several PFGE types a few isolates of
two to three PFGE-singleton types generally were clus-
tered into one GECM-7 type, or they were added to a
PFGE cluster of two to three isolates, e.g. G706-13 in-
cluding 3 PFGE type BA isolates and 3 isolates of PFGE
singleton types (Table 1). For the O25b-ST131, as well
as for the H30-Rx isolates, discordance was evident es-
pecially within the G706-11 type, which constituted 12
different PFGE types (Table 1).
In six instances, more than one GECM-7 type was
found within a PFGE ≥80% similarity cluster (Table 1
and Figs. 1 and 2). In cases of type Q and AS, the
similarity index for the isolates of different MLVA-
types was 92 and 96%, respectively, whereas in the
remaining four cases (i.e. PFGE types JB, DA, GA
and A), the isolates were indeed not completely iden-
tical with PFGE profiling. When using the higher cut-
off of ≥90% similarity, these isolates were separated
into PFGE subtypes with 80–89% identity. Thus, in
all of these cases, GECM-7 had a higher discrimin-
atory power than PFGE, using ≥80% profile similarity
for designation of types. This also included O25b
negative ST131 isolates that could be distinguished
from a O25b positive ST131 isolate, by GECM-7 but
not by PFGE (type JB, Tables 1 and 2).
The ST1444 outbreak isolates were clustered and
clearly distinguished from the epidemiologically unre-
lated isolates by both PFGE (type B) and GECM-7
(G707-02). For the O25b-ST131 outbreak isolates, one
epidemiologically unrelated isolate was added to the
PFGE type A outbreak cluster (Table 1, Fig. 1). Using
≥90% profile similarity, as generally recommended for
outbreak isolate identification, this isolate no longer
clustered with that part of the outbreak. GECM-7 was
able to separate this epidemiologically unrelated strain,
although it was unable to separate other unrelated
O25b-ST131 isolates from the outbreak isolates, includ-
ing four isolates that clustered in a clearly distinct
PFGE type (V).
Alternative methods for generating MLVA data
In order to increase the discriminatory power of MLVA,
Lobersli et al. added three loci, CCR001, CVN016 and
CVN017, to the original seven loci included in GECM-7
[23]. Additional discriminatory power was achieved by
adding the first two of these loci, with the exception of
the O25b-ST131 isolates (Tables 2 and 3). This resulted
in 60 distinct GECM-10 types, of which 44 were single-
tons. However, the GECM-10 did not elucidate the
discrepancies observed between MLVA and PFGE. The
most prominent changes that resulted from the use of
GECM-10 instead of GECM-7 were noted for the four
ST38 isolates within the GECM-7 type, G705-09, all of
which became singletons, as described above.
We also evaluated the use of either a system of arbi-
trary designations assigned to each allele, as first sug-
gested by Lindstedt et al. [36], or the actual fragment
size for designation of MLVA types as used by others
[22, 38], but we found very minor deviations from our
results obtained using repeat numbers.
Potential of MLVA for typing in standard consecutive
infection control surveillance
The number of repeats obtained within each loci varied
greatly (Table 3). Locus CVN017 was not detected at all,
and neither were CVN002, CVN003, and CVN016 in 78,
104, and 81 of the studied isolates, respectively. The
largest variation was seen for CVN014, followed by
CVN001 and CVN004. For the O25b-ST131 lineage and
its H30-Rx subclone, variation within each loci was
comparatively low; four loci were absent, four were
monomorphic and the remaining two (CVN014 and
CVN004) were dimorphic with regard to the number of
detected repeats/loci, Nor could these lineages be distin-
guished from the other isolates based on the presence of
a distinct allele within a certain locus.
Using the three loci of CVN001, CVN004, and CVN014,
which were present in all the isolates and showed varia-
tions in the number of repeats, a mini-MLVA, here desig-
nated as ʻGECM-3ʼ, was evaluated for application to the
initial screening of suspected transmission based on stand-
ard consecutive epidemiological screening. The discrimin-
atory power of GECM-3 was not much lower than that of
GECM-7 or GECM-10. Even though additional clustering
was noted, only three clusters with ≥5 isolates were
formed (Table 2). The ST1444 outbreak isolates could still
be distinguished from the other isolates. As expected, the
results for the O25b-ST131 lineage were unaltered when
GCEM-3 was used.
Discussion
The rapidly increasing number of ESBL-E.coli isolates
and the continuous influx of strains from the commu-
nity to hospital settings [4, 15, 39], make the surveillance
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of hospital transmission and alerting to potential out-
breaks a demanding challenge, even in low endemic
settings. With the aim of addressing this issue, we evalu-
ated the use of a generic E. coli MLVA [23, 36] on a set
of clinical isolates, representing more than 37 different
STs and 78 PFGE-types. The isolates represented almost
all consecutive sporadic cases from an entire region,
over a period of 6 months while a longstanding, initially
undetected polyclonal outbreak was ongoing [7]. The
sporadic cases had no apparent epidemiological relation-
ship with this outbreak nor with each other. Despite this,
but not surprisingly, clustering of isolates occurred in
varying degrees, depending on the method used, most
evident for MLST, followed by MLVA using three loci.
PFGE was the most discriminatory method, especially
with regard to the widespread ST131-O25b clone. Out-
break isolates belonging to this linage were clustered
with other sporadic cases using all methods; only PFGE
using ≥90% similarity index clearly distinguished these
outbreak isolates from the sporadic cases. The ST 1441
outbreak isolates were separated from the sporadic cases
with all methods tested.
MLVA that employed seven or ten loci showed almost
equivalent performance levels, and since the use of ten
loci for the MLVA (GECM-10) only slightly increased
the number of newly detected MLVA types, and only
within a limited number of STs, we focused on evaluat-
ing the performance of the protocol with seven loci
(GECM-7). However, some diversity in terms of the
numbers of repeats detected for the isolates was seen in
two of the three additional loci of the GCEM-10. The
addition of one of these loci improved the discriminatory
capacity, as reported in our previous study [7]. Similar
findings have been reported by others [40], suggesting
that these loci could be of interest to add when the use
of fewer loci generates inconclusive results.
The MLVA types corresponded to almost half the
number of STs. A subset of 11 STs were subdivided into
several MLVA-types, most prominent for ST38, ST648
and the ST131 cluster, when including isolates both
within and without the ST131-O25b lineage. By increas-
ing the number of loci from three to seven, ST 405, 617,
648 and 1284 were further subdivided into additional
MLVA-types, as were ST38 and ST131 by adding the
GECM-10 loci to those of GECM-7. Thus, MLVA gener-
ated substantial additional information to that of MLST.
Even though MLVA detected fewer types than PFGE, a
substantial number of GECM-7-types were generated,
and the PFGE clusters of isolates with similarities ≥80%
generally corresponded to a single GECM-7 type. Also,
in a few cases, GECM-7 analysis had a high discrimin-
atory efficacy and distinguished isolates within a PFGE ≥
80% similarity cluster as non-identical, suggesting that
the two methods could complement each other, compar-
able to what has been described for PFGE and spa-
typing for analysing MRSA [41].
Table 3 Frequency (%) of isolates with the designated number of repeats within each locus
No of repeatsa CVN001 CVN002 CVN003 CVN004 CVN007 CVN014 CVN015 CCR001 CVN016 CVN017
1 1
2 29 13 15 61 100
3 83 100 2 1 16 1
4 1 4 5 96 100
5 40 4 13 59 1
6 40 100 10 20 41
7 13 1 5 2 1
8 5 10 11
9 1 17
10 2 6 7
11 70 5 1
12 1 2 1
13 15 9
14 1 8 91
19 1
0 4 30
N 54 100 85 100 17 59 100 100 100
aThe outbreak isolates are included, i.e., nine O25b-ST131 isolates (GCEM-10 profile: 6-N-N-14-3-6-4-2-N-N) and three ST1444 isolates (GCEM-10
profile: 7-N-N-11-3-5-4-2-N-N)
Frequency (%) of isolates with the designated number of repeats within each of the loci for MLVA for the typing of 116 ESBL-E. coli isolates. The bolded loci correspond
to GECM-3 type MLVA and the seven first loci to that of GECM-7. The bold frequencies represent isolates that belong to the O25b-ST131 lineage (n = 34)
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ST131 is known to encompass a relatively wide range
of PFGE-types, including O25b and its subclones [42].
As expected, the discriminatory power of MLVA for the
various O25b-ST131 isolates was considerably lower
than that of PFGE. Variation in the number of repeats
was seen for this linage only within two MLVA loci, with
the remaining eight loci being monomorphic. For the
non-ST131 isolates, the variation within loci was consid-
erably higher. However, MLVA clearly distinguished
isolates of the ST131-O25b lineage from other isolates,
including other ST131 isolates. It delineated these iso-
lates further, as compared to PCR typing of O25b-ST131
and to the results obtained using the DiversiLab System
or MALDI-TOF mass spectrometry [2, 43–45], and pro-
vided additional information of value for the investiga-
tion of the described outbreak. However, our results
indicate that complementary methods are needed to ver-
ify or uncover strain relatedness within the O25b-ST131
lineage and its H30-Rx subclone. The majority of the
O25b-ST131 isolates in this study belonged to the H30-
Rx subclone. Even though this subclone is widespread
and of growing importance clinically [2, 18], a different
set of O25b- ST131 isolates might give different results,
depending on the local diversity of the lineages and the
extent of strain importation to the area.
For the time period studied and in our low-level en-
demic setting, it would have been sufficient to screen
using the three loci of the GECM-3 protocol, to obtain
rapid, reproducible and very easily interpreted typing in-
formation that could distinguish between isolate identity
and non-identity in a majority of cases. Sorting out
O25b-ST131 isolates beforehand by a PCR or more
recently described methods, might prove to be a time-
saving approach [44, 45]. Also, identity within epide-
miologically related isolates needs to be confirmed or
elucidated with additional loci or using additional
methods for resolving the most similar types. Since
the MLVA method is based on the analysis of loci
with a high degree of genetic variation [2, 25, 36, 46],
the MLVA patterns of strains disseminated within a
specific locale are likely to vary over time. Therefore,
if the GECM-3 protocol is used routinely, it is im-
portant to ascertain on a regular basis that the loci
chosen are able to discriminate between the isolates
that are circulating at the time.
Experience using MLVA for the typing of ESBL-
E.coli remains limited, with few published studies
[22, 36, 38, 40, 47, 48], and the lack of a common
database for researchers is a disadvantage. WGS is being
applied more and more in typing, especially for outbreak
investigations [19]. Despite dramatic technological pro-
gress in recent years, WGS is not yet readily applicable to
epidemiological surveillance of larger numbers of isolates
for the everyday work of many clinical laboratories,
especially with regard to assembly and interpretation is-
sues [49]. On the other hand, with an improving capability
of WGS to detect repetitive units, applying the MLVA
concept and identifying distinct variable parts of the gen-
ome and comparing these sequences, without the need to
interpret the whole genome, may indeed be a way to apply
WGS techniques with a MLVA approach in the future,
thereby also enabling the exchange of MLVA-like data
between laboratories.
Conclusion
With the alarming reports that the frequency of
carbapenemase-expressing Enterobacteriaceae is in-
creasing worldwide [50], also in low-level endemic
settings such as Scandinavia [51], the surveillance of
multidrug-resistant Enterobacteriaceae becomes increas-
ingly important. Variants of MLVA, including a method
reported for analysing Klebsiella spp [52], could play im-
portant roles as an effective first-step “screening” protocol
to exclude clonal relationships between isolates and to de-
cide whether an outbreak investigation should be initiated,
since prompt action is crucial in preventing further trans-
mission. We believe that the rapidity, technical simplicity
and ease of interpretation of MLVA, not least the mini-
GECM approach, makes it suitable as a “first-line-of-de-
fence” method in the epidemiological surveillance of
multidrug-resistant E. coli, preferably after first sorting out
isolates that are part of the O25b-ST131 lineage. It may
also act as a useful complement to traditional typing
methods, particularly at the local level, not the least for
smaller diagnostic laboratories. Indeed, the concept of
MLVA may prove to be even more useful when WGS
technologies become more readily available to most
laboratories.
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